Jennifer H. Hartt
Directeur/Membre du Conseil chez Jenrin Discovery LLC
Profil
Jennifer H.
Hartt is currently the Director at Jenrin Discovery LLC.
Previously, she worked as the Associate Director at the University of Pennsylvania, Managing Director of Healthcare Investment Group at Ben Franklin Technology Partners, Director at PhenoTech, Inc., and Observer at Invisalert Solutions, Inc. She also worked as a Principal at Drexel University.
Ms. Hartt completed her undergraduate degree at the University of Pennsylvania in 2006.
Postes actifs de Jennifer H. Hartt
| Sociétés | Poste | Début |
|---|---|---|
Jenrin Discovery LLC
 Jenrin Discovery LLC Pharmaceuticals: MajorHealth Technology Jenrin Discovery, Inc. develops therapeutics for chronic diseases. It provides therapeutics for various diseases, including obesity, diabetes, and autoimmune and inflammatory disorders. The company was founded by John F. McLeroy on April 17, 2007 and is headquartered in Philadelphia, PA. | Directeur/Membre du Conseil | - |
Anciens postes connus de Jennifer H. Hartt
| Sociétés | Poste | Fin |
|---|---|---|
Ben Franklin Technology Partners /Ventures/
 Ben Franklin Technology Partners /Ventures/ Investment ManagersFinance Ben Franklin Technology Partners /Ventures/ (Ben Franklin Tech Partners) is a venture Capital firm founded in 1982. The firm is headquartered in Philadelphia, Pennsylvania. | Private Equity Investor | 31/12/2022 |
Invisalert Solutions, Inc.
 Invisalert Solutions, Inc. Packaged SoftwareTechnology Services Invisalert Solutions, Inc. provides patient safety solutions. The firm offers ObservSMART, a wristband and software-based q15 minute check tracker that replaces pencil and paper-based forms. It specializes in resolving non-compliance issues in the acute healthcare, corrections, drug delivery, long-term care, youth and special education markets. The company was founded by Regina Widdows, Peter Nagy and Michele Marcolongo on August 20, 2014 and is headquartered in Newtown Square, PA. | Corporate Officer/Principal | - |
| University of Pennsylvania | Corporate Officer/Principal | - |
| Drexel University | Corporate Officer/Principal | - |
PhenoTech, Inc.
 PhenoTech, Inc. BiotechnologyHealth Technology PhenoTech, Inc. develops and markets monoclonal antibodies which are used in blood diagnostic and therapeutic applications. It offers blood diagnostic reagents, such as nanoscale emissive antibody-complexes for typing reagents for pre-transfusion testing. The company was founded by Eric Ostertag in 2003 and is headquartered in Philadelphia, PA. | Directeur/Membre du Conseil | - |
Formation de Jennifer H. Hartt
| University of Pennsylvania | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Jenrin Discovery LLC
Jenrin Discovery LLC Pharmaceuticals: MajorHealth Technology Jenrin Discovery, Inc. develops therapeutics for chronic diseases. It provides therapeutics for various diseases, including obesity, diabetes, and autoimmune and inflammatory disorders. The company was founded by John F. McLeroy on April 17, 2007 and is headquartered in Philadelphia, PA. | Health Technology |
Invisalert Solutions, Inc.
Invisalert Solutions, Inc. Packaged SoftwareTechnology Services Invisalert Solutions, Inc. provides patient safety solutions. The firm offers ObservSMART, a wristband and software-based q15 minute check tracker that replaces pencil and paper-based forms. It specializes in resolving non-compliance issues in the acute healthcare, corrections, drug delivery, long-term care, youth and special education markets. The company was founded by Regina Widdows, Peter Nagy and Michele Marcolongo on August 20, 2014 and is headquartered in Newtown Square, PA. | Technology Services |
Ben Franklin Technology Partners /Ventures/
Ben Franklin Technology Partners /Ventures/ Investment ManagersFinance Ben Franklin Technology Partners /Ventures/ (Ben Franklin Tech Partners) is a venture Capital firm founded in 1982. The firm is headquartered in Philadelphia, Pennsylvania. | Finance |
PhenoTech, Inc.
PhenoTech, Inc. BiotechnologyHealth Technology PhenoTech, Inc. develops and markets monoclonal antibodies which are used in blood diagnostic and therapeutic applications. It offers blood diagnostic reagents, such as nanoscale emissive antibody-complexes for typing reagents for pre-transfusion testing. The company was founded by Eric Ostertag in 2003 and is headquartered in Philadelphia, PA. | Health Technology |
